HKU Scholars Hub: Browsing DSpace

Browsing by Author Berg, T

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 2 to 12 of 12 < previous

	Title	Author(s)	Issue Date	Views
	HBsAg loss after nucleo(s)tide analogue withdrawal: relationship with viral antigen levels and hbv genotype Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Sonneveld, MJ Chiu, S-M Park, JY Kaewdech, A Seto, WKW Tanaka, Y Carey, I Papatheodoridi, M Van Bömmel, F Brakenhoff, S Berg, T Zoulim, F Ahn, SH Dalekos, GN Erler, NS Zu Siederdissen, CN Wedemeyer, H Cornberg, M Yuen, RMF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, G Chen, CH Maasoumy, B CREATE study group,	2021
	HBV DNA AND HBSAG LEVELS AT 24 WEEKS OFF-TREATMENT PREDICT CLINICAL RELAPSE AND HBSAG LOSS IN HBEAG NEGATIVE PATIENTS WHO DISCONTINUED ANTIVIRAL THERAPY Journal:Gastroenterology	Sonneveld, MJ Chiu, S-M Park, JY Brakenhoff, SM Kaewdech, A Seto, WK Tanaka, Y Carey, I Papatheodoridi, M Colombatto, P Van Bömmel, F Janssen, HL Berg, T Zoulim, F Ahn, SH Dalekos, GN Erler, NS Brunetto, M Wedemeyer, H Cornberg, M Yuen, MF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, G Chen, C-H Maasoumy, B	26-Sep-2023
	IFN-lambda3, not IFN-lambda4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis Journal:Nat Genet	Eslam, M McLeod, D Kelaeng, KS Mangia, A Berg, T Thabet, K Irving, WL Dore, GJ Sheridan, D Gronbaek, H Abate, ML Hartmann, R Bugianesi, E Spengler, U Rojas, A Booth, DR Weltman, M Mollison, L Cheng, W Riordan, S Mahajan, H Fischer, J Nattermann, J Douglas, MW Liddle, C Powell, E Romero-Gomez, M George, J International Liver Disease Genetics, C Leung, CMR	2017	36
	Lower Pre-Treatment HBV DNA Levels Are Associated With Better Off-Treatment Outcomes After Nucleo(S)Tide Analogue Withdrawal In Patients With Chronic Hepatitis B Proceeding/Conference:Hepatology	Sonneveld, MJ Chiu, SM Park, JY Brakenhoff, S Kaewdech, A Seto, WK Tanaka, Y Carey, I Papatheodoridi, M Colombatto, P Van Bommel, F Berg, T Zoulim, F Ahn, SH Dalekos, GN Erler, NS Brunetto, M Wedemeyer, H Cornberg, M Yuen, MF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, GV Chen, CH Maasoumy, B	31-Oct-2022
	MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C Journal:Nature Communications	Thabet, K Asimakopoulos, A Shojaei, M Romero-Gomez, M Mangia, A Irving, WL Berg, T Dore, GJ Gronbaek, H Sheridan, D Abate, ML Bugianesi, E Weltman, M Mollison, L Cheng, W Riordan, S Fischer, J Spengler, U Nattermann, J Wahid, A Rojas, A White, R Douglas, MW McLeod, D Powell, E Liddle, C van der Poorten, D George, J Eslam, M International Liver Disease Genetics, C Leung, CMR	2016	47
	Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B Journal:New England Journal of Medicine	Lau, GK Piratvisuth, T Luo, KX Marcellin, P Thongsawat, S Cooksley, G Gane, E Fried, MW Chow, WC Paik, SW Chang, WY Berg, T Flisiak, R McCloud, P Pluck, N	2005	136
	Prediction of sustained response after nucleo(s)tide analogue cessation using HBsAg and HBcrAg levels – a multicenter study (CREATE) Proceeding/Conference:Hepatology	Sonneveld, MJ Park, JY Kaewdech, A Seto, WKW Tanaka, Y Carey, I Papatheodoridi, M Van Bömmel, F Berg, T Zoulim, F Ahn, SH Dalekos, GN Erier, NS Höner zu SiederdissenC, C Wedemeyer, H Comberg, M Yuen, RMF Agarwal, K Boonstra, A Ferret, MAB Piratvisuth, T Papatheodoridis, G Maasoumy, B CREATE study group,	2020	12
	Prediction Of Sustained Response After Nucleo(s)tide Analogue Cessation Using Hbsag And Hbcrag Levels – A Multicenter Study (create) Journal:Clinical Gastroenterology and Hepatology	Sonneveld, MJ Park, JY Kaewdech, A Seto, WK Tanaka, Y Carey, I Papatheodoridi, M van Bommel, F Berg, T Zoulim, F Ahn, SH Dalekos, GN Erler, NS Honer zu Siederdissen, C Wedemeyer, H Cornberg, M Yuen, MF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, G Maasoumy, B	2020	36
	Predictors of HBsAg loss after cessation of nucleo (s)tide analogue therapy in asian patients with low HBsAg levels. Poster Presentation (SAT344) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Sonneveld1, M Chiu, SM Park, JY Kaewdech, A Seto, WKW Tanaka, Y Carey, I Papatheodoridi, M van Bömmel, F Brakenhoff, S Berg, T Zoulim, F Ahn, SH Dalekos, G Erler, N Hoener zu Siederdissen, C Wedemeyer1, H Cornberg, M Yuen, RMF Agarwa, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis8, G Chen, C-H Maasoumy, B	2022	1
	Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels Journal:Journal of Hepatology	Sonneveld, MJ Chiu, SM Park, JY Brakenhoff, SM Kaewdech, A Seto, WKW Tanaka, Y Carey, I Papatheodoridi, M van Bommel, F Berg, T Zoulim, F Ahn, SH Dalekos, GS Erler, NS Honer zu Siederdissen, C Wedemeyer, H Cornberg, M Yuen, RMF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, G Chen, CH Maasoumy, B	2022	6
	Update of the statements on biology and clinical impact of occult hepatitis B virus infection Journal:Journal of Hepatology	Raimondo, G Locarnini, S Pollicino, T Levrero, M Zoulim, F Lok, AS Allain, JP Berg, T Bertoletti, A Brunetto, MR Bruno, R Chen, DS Coppola, N Cornberg, M Craxì, A Dandri, M Di Marco, V Ferrari, C Gaeta, GB Glebe, D Guidotti, LG Kramvis, A Lampertico, P Li, C Liang, J Marzano, A Michalak, TI Pawlotsky, JM Prati, D Puoti, M Samuel, D Soriano, V Squadrito, G Sureau, C Trepo, C Yuen, MF	2019	51

Showing results 2 to 12 of 12 < previous